tiprankstipranks
Madrigal Pharmaceuticals price target raised to $427 from $415 at JMP Securities
PremiumThe FlyMadrigal Pharmaceuticals price target raised to $427 from $415 at JMP Securities
1M ago
Madrigal Pharmaceuticals price target raised to $400 from $350 at Oppenheimer
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $400 from $350 at Oppenheimer
2M ago
Paulson takes new stake in Southwestern Energy, exits AngloGold Ashanti
Premium
The Fly
Paulson takes new stake in Southwestern Energy, exits AngloGold Ashanti
2M ago
Madrigal Pharmaceuticals Reports Strong Rezdiffra Launch
PremiumCompany AnnouncementsMadrigal Pharmaceuticals Reports Strong Rezdiffra Launch
3M ago
Madrigal Pharmaceuticals price target raised to $394 from $377 at Canaccord
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $394 from $377 at Canaccord
3M ago
Madrigal Pharmaceuticals reports Q3 EPS ($4.92), consensus ($6.91)
Premium
The Fly
Madrigal Pharmaceuticals reports Q3 EPS ($4.92), consensus ($6.91)
3M ago
Madrigal Pharmaceuticals completes enrollment of study of Resmetirom
PremiumThe FlyMadrigal Pharmaceuticals completes enrollment of study of Resmetirom
3M ago
Madrigal Pharmaceuticals management to meet with JMP Securities
Premium
The Fly
Madrigal Pharmaceuticals management to meet with JMP Securities
4M ago
Madrigal Pharmaceuticals appoints Michael Charlton as SVP, clinical development
Premium
The Fly
Madrigal Pharmaceuticals appoints Michael Charlton as SVP, clinical development
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100